Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.
News

Next-generation sequencing test detects pathogens with high sensitivity
- Author:
- Jennifer Smith
NEW ORLEANS – The test detected pathogens with 92% sensitivity, which was more sensitive than conventional testing methods.
News

Inhibitor may overcome ibrutinib resistance in MCL
- Author:
- Jennifer Smith
The inhibitor, IACS-010759, decreased tumor growth and prolonged survival in mouse models of ibrutinib-resistant lymphoma.
Video

Researchers propose new risk groups for NK-AML
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Investigators used machine learning algorithms to risk stratify patients with normal karyotype acute myeloid leukemia.
News

Gabapentin falls short in treating sickle cell pain
- Author:
- Jennifer Smith
NEW ORLEANS – Gabapentin plus standard therapy produced results similar to those of placebo plus standard therapy.
News

Researchers win Stand Up To Cancer grants
- Author:
- Jennifer Smith
Five teams received funding for research into leukemia and lung, colon, pancreatic, breast, and ovarian cancers.
Video

Combo proves most effective in HMA-naive, higher-risk MDS
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Oral rigosertib plus azacitidine produced a 90% response rate in higher-risk patients with myelodysplastic syndromes who...
Video

More abnormal cells linked to poorer ASCT outcomes in MDS
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Patients with more than 60% cytogenetically abnormal cells at transplant had inferior overall survival and relapse-free...
News

LentiGlobin reduces transfusion dependence in young thalassemia patients
- Author:
- Jennifer Smith
NEW ORLEANS – Children and young adults with non-beta0/beta0 thalassemia achieved transfusion independence in two trials.
Video

Biomarker testing may transform treatment of acute GVHD
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Testing patient blood samples for two biomarkers may help guide early treatment of acute GVHD.
News
Tagraxofusp produces high response rate in BPDCN
- Author:
- Jennifer Smith
The overall response rate was 90% in previously untreated patients who received the highest dose.
Video

Model inspired by Netflix, Amazon may help guide MDS treatment
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – The researchers used an algorithm to help predict response or resistance to lenalidomide with a high degree of accuracy....
News

Researchers to be honored at ASPHO
- Author:
- Jennifer Smith
Hematology and oncology researchers will receive awards at the 2019 American Society of Pediatric Hematology/Oncology conference.
Video

Sorafenib plus GCLAM held safe in AML, MDS phase-1 study
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Sorafenib plus GCLAM has shown promise in a phase 1 trial of patients with AML and MDS.
Video

Study highlights lack of data on transgender leukemia patients
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.
Video

ALF 2019 showcases evolving treatment of AML
- Author:
- Jennifer Smith
NEWPORT BEACH, CALIF. – Dr. Martin Tallman discusses meeting presentations on the treatment of AML.